Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 42, n° 3
pages 480-489 (mars 2000)
Doi : 10.1016/S0190-9622(00)90223-8
Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease

Patrick Walsh, MD, Peter Gibbs, MD, René Gonzalez, MD
Departments of Dermatology and Medicine (Division of Medical Oncology), University of Colorado School of Medicine. Denver, Colorado 


Our objective in this article is to update dermatologists on the clinical management of malignant melanoma, including the role of sentinel node biopsy and options for the treatment of stage III and stage IV disease. The role of the dermatologist throughout the continuum of care is emphasized, and the essential partnership with medical oncology in recognizing promising new options for patients with advanced disease is examined. (J Am Acad Dermatol 2000;42:480-9.)

The full text of this article is available in PDF format.

 Reprint requests: René Gonzalez, MD, Melanoma Research Clinics, 4200 E Ninth Ave, Box E-190, Denver, CO 80262. E-mail: .

*  *Information regarding several biochemotherapy trials including eligibility criteria and contact information is available at the PDQ database at http://cancernet.NCI.NIH.GOV/trials/users.html .

© 2000  American Academy of Dermatology, Inc. Published by Elsevier Masson SAS@@#104157@@